» Articles » PMID: 29345411

Ethnicity, Socioeconomic Status and the Severity and Course of Non-cystic Fibrosis Bronchiectasis

Overview
Journal Intern Med J
Specialty General Medicine
Date 2018 Jan 19
PMID 29345411
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: This study evaluated whether there are ethnic factors which affect the severity and progression of bronchiectasis in our adult multi-ethnic population in Auckland, New Zealand.

Methods: Clinical records were reviewed from patients attending the outpatient facilities of our institution between 2007 and 2010. Data collected included demographics, clinical features, smoking status, self-reported ethnicity, socioeconomic status (NZDep), pulmonary function and sputum microbiology.

Results: A total of 437 patients was identified: median age 65 years, 66% female, mean forced expiratory volume in the first second (FEV ) 62.4% predicted, and 10.5% of patients had recurrent growth of Pseudomonas aeruginosa. Patients of Maori and Pacific ethnicity were overrepresented compared to the institution population catchment and had more severe impairment of lung function: mean % predicted FEV for Pacific 52.0, Maori 58.6, European 68.6, Asian 64.2 (P < 0.0001). This was independent of socioeconomic status. However, no overall decline was seen in serial lung function measurements, either across the whole cohort or in any particular ethnic group.

Conclusions: Patients of Maori and Pacific ethnicity are both overrepresented and have more severe bronchiectasis in this cohort, independent of socioeconomic status. Ethnicity did not predict decline in pulmonary function. Further studies into genetic predisposition to bronchiectasis in Maori or Pacific people may be warranted.

Citing Articles

Epidemiology of bronchiectasis.

Nigro M, Laska I, Traversi L, Simonetta E, Polverino E Eur Respir Rev. 2024; 33(174).

PMID: 39384303 PMC: 11462313. DOI: 10.1183/16000617.0091-2024.


A systematic literature review of the clinical and socioeconomic burden of bronchiectasis.

Chalmers J, Mall M, McShane P, Nielsen K, Shteinberg M, Sullivan S Eur Respir Rev. 2024; 33(173).

PMID: 39231597 PMC: 11372470. DOI: 10.1183/16000617.0049-2024.


Factors influencing survival and mortality among adult Aboriginal Australians with bronchiectasis-A 10-year retrospective study.

Heraganahally S, Gibbs C, J Ravichandran S, Erdenebayar D, Abeyaratne A, Howarth T Front Med (Lausanne). 2024; 11:1366037.

PMID: 38774399 PMC: 11106411. DOI: 10.3389/fmed.2024.1366037.


Hospital admission rates and related outcomes among adult Aboriginal australians with bronchiectasis - a ten-year retrospective cohort study.

Howarth T, Gibbs C, Heraganahally S, Abeyaratne A BMC Pulm Med. 2024; 24(1):118.

PMID: 38448862 PMC: 10918854. DOI: 10.1186/s12890-024-02909-x.


Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.

Heraganahally S, Howarth T, Issac S, Lloyd A, J Ravichandran S, Abeyaratne A BMJ Open Respir Res. 2023; 10(1).

PMID: 36878611 PMC: 9990608. DOI: 10.1136/bmjresp-2022-001508.